Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56


Impact of different type of cancer treatment on the effectiveness of breast reconstruction.

Szloch J, Marczyk E, Kołodziej-Rzepa M, Komorowski AL.

Gland Surg. 2016 Aug;5(4):444-9. doi: 10.21037/gs.2016.05.06.


Adjuvant systemic therapy in older women with breast cancer.

Leone J, Leone BA, Leone JP.

Breast Cancer (Dove Med Press). 2016 Jul 25;8:141-7. doi: 10.2147/BCTT.S110765. eCollection 2016. Review.


Adjuvant endocrine therapy in premenopausal women with breast cancer.

Kadakia KC, Henry NL.

Clin Adv Hematol Oncol. 2015 Oct;13(10):663-72.


The impact of Anastrazole and Letrozole on the metabolic profile in an experimental animal model.

Boutas I, Pergialiotis V, Salakos N, Agrogiannis G, Konstantopoulos P, Korou LM, Kalampokas T, Gregoriou O, Creatsas G, Perrea D.

Sci Rep. 2015 Dec 1;5:17493. doi: 10.1038/srep17493.


When are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data.

Walker AJ, West J, Card TR, Crooks C, Kirwan CC, Grainge MJ.

Blood. 2016 Feb 18;127(7):849-57; quiz 953. doi: 10.1182/blood-2015-01-625582. Epub 2015 Nov 16.


Comparative study on individual aromatase inhibitors on cardiovascular safety profile: a network meta-analysis.

Zhao X, Liu L, Li K, Li W, Zhao L, Zou H.

Onco Targets Ther. 2015 Sep 29;8:2721-30. doi: 10.2147/OTT.S88179. eCollection 2015.


Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy.

Santa-Maria CA, Blackford A, Nguyen AT, Skaar TC, Philips S, Oesterreich S, Rae JM, Desta Z, Robarge J, Henry NL, Storniolo AM, Hayes DF, Blumenthal RS, Ouyang P, Post WS, Flockhart DA, Stearns V; Consortium on Breast Cancer Pharmacogenomics (COBRA).

Clin Cancer Res. 2016 Mar 15;22(6):1395-402. doi: 10.1158/1078-0432.CCR-15-1213. Epub 2015 Oct 13.


Molecular Heterogeneity in Primary Breast Carcinomas and Axillary Lymph Node Metastases Assessed by Genomic Fingerprinting Analysis.

Ellsworth RE, Toro AL, Blackburn HL, Decewicz A, Deyarmin B, Mamula KA, Costantino NS, Hooke JA, Shriver CD, Ellsworth DL.

Cancer Growth Metastasis. 2015 Jul 20;8:15-24. doi: 10.4137/CGM.S29490. eCollection 2015.


Optimal approach in early breast cancer: Adjuvant and neoadjuvant treatment.

Ribeiro J, Sousa B, Cardoso F.

EJC Suppl. 2013 Sep;11(2):3-22. doi: 10.1016/j.ejcsup.2013.07.029. Review. No abstract available.


Adjuvant Systemic Therapy in Older Breast Cancer Women: Can We Optimize the Level of Care?

Mislang AR, Biganzoli L.

Cancers (Basel). 2015 Jul 3;7(3):1191-214. doi: 10.3390/cancers7030833. Review.


Influence of CYP19A1 polymorphisms on the treatment of breast cancer with aromatase inhibitors: a systematic review and meta-analysis.

Artigalás O, Vanni T, Hutz MH, Ashton-Prolla P, Schwartz IV.

BMC Med. 2015 Jun 11;13:139. doi: 10.1186/s12916-015-0373-9.


Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.

Bodai BI, Tuso P.

Perm J. 2015 Spring;19(2):48-79. doi: 10.7812/TPP/14-241. Review.


Role of bone-anabolic agents in the treatment of breast cancer bone metastases.

Suvannasankha A, Chirgwin JM.

Breast Cancer Res. 2014;16(6):484. Review.


A comparison of letrozole and anastrozole followed by letrozole in breast cancer patients.

Aphinives P, Vachirodom D, Thanapaisal C, Rangsrikajee D, Somintara O.

Breast Cancer (Dove Med Press). 2015 Jan 20;7:37-41. doi: 10.2147/BCTT.S73997. eCollection 2015.


Perspectives of postmenopausal breast cancer survivors on adjuvant endocrine therapy-related symptoms.

van Londen GJ, Donovan HS, Beckjord EB, Cardy AL, Bovbjerg DH, Davidson NE, Morse JQ, Switzer GE, Verdonck-de Leeuw IM, Dew MA.

Oncol Nurs Forum. 2014 Nov 1;41(6):660-8. doi: 10.1188/14.ONF.660-668.


Management options of breast cancer related osteoporosis.

Becorpi A, Sisti G, Sorbi F, Malosso ER, Guaschino S.

Clin Cases Miner Bone Metab. 2014 May;11(2):110-3. Review.


Effects of switching from anastrozole to letrozole, due to reimbursement policy, on the outcome of breast cancer therapy.

Aphinives P, Vachirodom D, Thanapaisal C, Rangsrikajee D, Somintara O.

Breast Cancer (Dove Med Press). 2014 Aug 27;6:145-50. doi: 10.2147/BCTT.S67553. eCollection 2014.


Association of tamoxifen use and increased diabetes among Asian women diagnosed with breast cancer.

Sun LM, Chen HJ, Liang JA, Li TC, Kao CH.

Br J Cancer. 2014 Oct 28;111(9):1836-42. doi: 10.1038/bjc.2014.488. Epub 2014 Sep 16.


Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomics.

Liu M, Goss PE, Ingle JN, Kubo M, Furukawa Y, Batzler A, Jenkins GD, Carlson EE, Nakamura Y, Schaid DJ, Chapman JA, Shepherd LE, Ellis MJ, Khosla S, Wang L, Weinshilboum RM.

Mol Endocrinol. 2014 Oct;28(10):1740-51. doi: 10.1210/me.2014-1147. Epub 2014 Aug 22.

Items per page

Supplemental Content

Support Center